Daily FNArena News - Australia

Analysts raise 12-month targets for Pinnacle Investment Management after rising equity markets boosted funds under management and performance fees

Sleep treatment leader ResMed has faced a number of headwinds but has surprised analysts with a strong improvement in gross margins

The ASX200 outperformed overseas indices in July aided by ongoing strength in bank share prices

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

Analysts remain enthusiastic around the specialist platform sector based on an improving net flow environment

Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements

Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements

New research on the Pharmaceutical Wholesaling sector identifies three stocks with long-term defensive growth within an improving government funding framework